Select Equity Group, L.P. / TMO
Select Equity Group, L.P.’s Thermo Fisher Scientific Inc Position
Does Select Equity Group, L.P. own Thermo Fisher Scientific Inc (TMO)? Yes — 299.5K shares worth $147M (+0.75% of its 13F portfolio) as of Q1 2026, down from 315.0K shares the prior filed quarter.
Position Value
$147M
Q1 2026
Shares
299.5K
% of Portfolio
+0.75%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 299.5K | $147M | +0.75% |
| Q4 2025 | 315.0K | $183M | +0.79% |
| Q3 2025 | 161.5K | $78M | +0.32% |
| Q2 2025 | 146.5K | $59M | +0.25% |
| Q1 2025 | 135.9K | $68M | +0.29% |
| Q4 2024 | 201.0K | $105M | +0.42% |
| Q3 2024 | 256.4K | $159M | +0.57% |
| Q2 2024 | 328.9K | $182M | +0.72% |
| Q1 2024 | 310.8K | $181M | +0.64% |
| Q4 2023 | 596.4K | $317M | +1.13% |
| Q3 2023 | 643.8K | $326M | +1.34% |
| Q2 2023 | 503.5K | $263M | +0.98% |
| Q1 2023 | 232.9K | $134M | +0.48% |
| Q4 2022 | 295.1K | $163M | +0.61% |
| Q3 2022 | 274.9K | $139M | +0.49% |
| Q2 2022 | 309.4K | $168M | +0.54% |
| Q1 2022 | 313.3K | $185M | +0.60% |
| Q4 2021 | 321.5K | $215M | +0.58% |
| Q3 2021 | 469.1K | $268.0B | +0.90% |
| Q2 2021 | 576.3K | $290.7B | +0.99% |
| Q1 2021 | 558.4K | $254.8B | +0.93% |
| Q4 2020 | 547.0K | $254.8B | +1.05% |
| Q3 2020 | 363.2K | $160.3B | +0.79% |
| Q2 2020 | 400.7K | $145.2B | +0.83% |
| Q1 2020 | 419.5K | $119.0B | +0.82% |
| Q4 2019 | 478.0K | $155.3B | +0.98% |
| Q3 2019 | 474.7K | $138.3B | +0.94% |
| Q2 2019 | 423.6K | $124.4B | +0.85% |
| Q1 2019 | 550.9K | $150.8B | +1.02% |
| Q4 2018 | 1.06M | $237.9B | +1.80% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Select Equity Group, L.P.’s full portfolio or all institutional holders of TMO.